Literature DB >> 25150011

Regulated cell death: signaling and mechanisms.

Avi Ashkenazi1, Guy Salvesen.   

Abstract

Cell turnover is a fundamental feature in metazoans. Cells can die passively, as a consequence of severe damage to their structural integrity, or actively, owing to a more confined biological disruption such as DNA damage. Passive cell death is uncontrolled and often harmful to the organism. In contrast, active cell death is tightly regulated and serves to support the organism's life. Apoptosis-the primary form of regulated cell death-is relatively well defined. Necroptosis-an alternative, distinct kind of regulated cell death discovered more recently-is less well understood. Apoptosis and necroptosis can be triggered either from within the cell or by extracellular stimuli. Certain signaling components, including several death ligands and receptors, can regulate both processes. Whereas apoptosis is triggered and executed via intracellular proteases called caspases, necroptosis is suppressed by caspase activity. Here we highlight current understanding of the key signaling mechanisms that control regulated cell death.

Keywords:  RIP; TNF; apoptosis; caspase; death receptor; necroptosis; receptor interacting protein; tumor necrosis factor

Mesh:

Substances:

Year:  2014        PMID: 25150011     DOI: 10.1146/annurev-cellbio-100913-013226

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  98 in total

1.  Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-γ.

Authors:  Alison G Stanbery; Zachary R Newman; Gregory M Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

2.  Engineered cellular gene-replacement platform for selective and inducible proteolytic profiling.

Authors:  Charles W Morgan; Juan E Diaz; Samantha G Zeitlin; Daniel C Gray; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

Review 3.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

Review 4.  Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.

Authors:  W Joost Lesterhuis; Anthony Bosco; Michael J Millward; Michael Small; Anna K Nowak; Richard A Lake
Journal:  Nat Rev Drug Discov       Date:  2017-01-06       Impact factor: 84.694

5.  FANCD2 protects against bone marrow injury from ferroptosis.

Authors:  Xinxin Song; Yangchun Xie; Rui Kang; Wen Hou; Xiaofang Sun; Michael W Epperly; Joel S Greenberger; Daolin Tang
Journal:  Biochem Biophys Res Commun       Date:  2016-10-20       Impact factor: 3.575

6.  The action and mechanism of myrislignan on A549 cells in vitro and in vivo.

Authors:  XinGang Lu; Liu Yang; JingXian Chen; JiAn Zhou; XiaoDan Tang; YingGang Zhu; HongFu Qiu; Jie Shen
Journal:  J Nat Med       Date:  2016-08-04       Impact factor: 2.343

7.  TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury.

Authors:  Peixiang Lan; Yihui Fan; Yue Zhao; Xiaohua Lou; Howard P Monsour; Xiaolong Zhang; Yongwon Choi; Yaling Dou; Naoto Ishii; Rafik M Ghobrial; Xiang Xiao; Xian Chang Li
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

Review 8.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

Review 9.  Long and short (timeframe) of endoplasmic reticulum stress-induced cell death.

Authors:  Hyung Don Ryoo
Journal:  FEBS J       Date:  2016-06-06       Impact factor: 5.542

10.  X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.

Authors:  Margherita Sisto; Loredana Lorusso; Sabrina Lisi
Journal:  Clin Exp Med       Date:  2015-12-11       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.